Clinical Trial Update: Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hyperthermic intraperitoneal chemotherapy with paclitaxel in advanced epithelial ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: PEDRO VILLAREJO CAMPOS | Conditions: Epithelial Ovarian Cancer | Phase 3 | Status: UNKNOWN